******* Featured Article ******* Stem Cell Therapy Shows Encouraging Results in Type 1 Diabetes Treatment

The Abu Dhabi Stem Cells Center (ADSCC) has successfully administered umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy to a 20-year-old Emirati patient with Type 1 diabetes. One month post-treatment, the patient showed significant improvements in blood sugar levels and diabetes-related antibodies, with ongoing monitoring indicating further benefits.
The Role of Rose Stem Cell-Derived Exosomes in Skin Regeneration and Repair

A case series examining rose stem cell-derived exosomes (RSCEs) highlights their potential role in treating atopic dermatitis, hyperpigmentation, scarring, wounds, melasma, and skin aging. The findings suggest RSCEs exhibit antioxidant and anti-inflammatory properties, contributing to favorable clinical outcomes.
ALLELE Study Confirms Tabelecleucel’s Efficacy in R/R Epstein-Barr + PTLD

Updated results from the Phase 3 ALLELE study confirm the efficacy, safety, and durability of tabelecleucel in treating relapsed or refractory Epstein-Barr virus-positive post-transplant lymphoproliferative disease (R/R EBV+ PTLD) presented at the 66th American Society of Hematology (ASH) Annual Meeting.
Long-Term Efficacy and Safety of Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn’s Disease

A five-year follow-up study evaluates the long-term clinical and radiological outcomes of mesenchymal stem cell therapy for perianal fistulising Crohn’s disease. The results show promising clinical remission and symptom control.
How Exosome Facials Support Skin Regeneration for a Youthful Glow

Exosome facials provide a natural way to enhance skin health by promoting collagen production and supporting skin renewal. This non-invasive treatment helps reduce fine lines and wrinkles, offering a more youthful and smoother complexion.
miR-302b Exosomal Delivery Reverses Senescent Cell Arrest in Aging Mice

This study highlights the role of exosomal miR-302b in reversing the proliferative arrest of senescent cells (SnCs) in aging mice, demonstrating improvements in lifespan, physical performance, and cognition. The findings suggest that exosomal miR-302b could provide a potential strategy for addressing aging and senescence-related disorders.